Ral-binding protein 1 (RALBP1)

Ral-binding protein 1 (RALBP1), also known as RLIP76, is a multi-functional protein that serves as a critical effector in the Ral GTPase signaling pathway and functions as a non-ABC (ATP-binding cassette) transporter. It plays a pivotal role in clathrin-mediated endocytosis by interacting with the AP2 complex and regulates mitochondrial dynamics and mitotic spindle assembly during the cell cycle (UniProt Q15311). In the context of oncology, RALBP1 is frequently overexpressed in various malignancies, including lung, colon, and breast cancers, where it promotes cell survival, migration, and resistance to apoptosis (PMID: 25103498). A key feature of RALBP1 is its ability to catalyze the ATP-dependent efflux of glutathione-conjugates and diverse chemotherapeutic agents, making it a major contributor to multidrug resistance (MDR) (PMID: 19448679). Beyond cancer, RALBP1 has been implicated in the pathogenesis of metabolic syndrome and neurodegenerative conditions like Alzheimer's disease due to its role in oxidative stress management (PMID: 24184453). Therapeutic strategies targeting RALBP1, such as antisense oligonucleotides or small-molecule inhibitors, aim to sensitize cancer cells to chemotherapy and disrupt oncogenic signaling cascades (PMID: 21859405).

Other names

RLIP76RLIP76-kDa Ral-interacting proteinRal-interacting protein 1

Inhibition of the ATP-dependent transport of glutathione-conjugates and xenobiotics, leading to the intracellular accumulation of toxic metabolites and chemotherapeutic drugs, which induces apoptosis and overcomes multidrug resistance; additionally, disruption of Ral-mediated oncogenic signaling pathways.